Some aspects of immunotherapy in colon cancer

by M. Yu. Fedyanin, Kh. Kh.-M. El’snukaeva, A. A. Tryakin, S. A. Tyulyandin
Published 2018-05-01

Circulating tumor DNA as a marker of residual tumor in colon cancer

by M. Yu. Fedyanin, Kh. Kh.-M. Elsnukaeva, V. A. Aliev, T. S. Ayrapetyan, A. V. Polyakov, E. V. Moroz, V. A. Uymanov, U. A. Boyarskikh, A. A. Kechin, M. L. Filipenko, S. А. Tjulandin
Published 2018-11-01

Efficacy of first-line oxaliplatin-based chemotherapy regimens depending on the KRAS mutation status

by M. Yu. Fedyanin, Kh. Kh.-M. El’snukaeva, I. A. Pokataev, A. A. Tryakin, A. A. Bulanov, O. V. Sekhina, D. A. Chekini, E. O. Ignatova, S. S. Gordeev, M. D. Budurova, Z. Mamedli, D. V. Podluzhnyy, N. A. Kozlov, S. A. Tyulyandin
Published 2018-05-01

FOLFOXIRI in patients with colon cancer and isolated non-resectable liver metastases: phase II prospective non-randomized single-center study

by M. Yu. Fedyanin, E. M. Polyanskaya, I. A. Pokataev, A. A. Tryakin, O. V. Sekhina, D. A. Chekini, Kh.-Kh. M. Elsnukaeva, A. N. Polyakov, I. V. Sagaydak, V. D. Podluzhniy, V. A. Aliev, S. S. Gordeev, D. V. Kuzmichev, Z. Z. Mamedli, S. A. Tjulandin
Published 2019-11-01

Metastasectomy in patients with non-resectable metastatic colorectal cancer receiving chemotherapy and anti-EGFR antibodies: a prospective, non-randomized, multicenter, phase II st...

by M. Yu. Fedyanin, L. Yu. Vladimirova, N. A. Abramova, A. E. Storozhakova, I. L. Popova, N. M. Tikhanovskaya, E. A. Kalabanova, Е. G. Panina, A. I. Arzamastseva, E. G. Rybakov, L. V. Bolotina, T. V. Ustinova, А. А. Kachmazov, I. A. Pokataev, A. A. Tryakin, O. V. Sekhina, D. A. Chekini, Kh. Kh.-M. Elsnukaeva, D. V. Podluzhniy, S. A. Tjulandin, O. I. Kit
Published 2019-06-01